4
Total investments
2
Early stage
0
Mid stage
1
Late stage
8y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Aug 2018
Homework help, private lessons, and study guidance all in one place. Thousands of tutors ready to assist instantly, every day, all day, and in every subject!
Investor
Mar 2018
Moon Express, Inc. (MoonEx) is a privately funded commercial space company blazing a trail to the Moon to unlock its mysteries and resources with low cost robotic spacecraft products & services using exponential technologies. Driven by long-term goals of exploring and developing lunar resources for the benefit of humanity, the company has short-term business on-ramps of providing lunar transportation and services for government and commercial customers. NASA partnered with Moon Express in 2014 under its Lunar CATALYST program to help build the capability to return the United States to the surface of the Moon. In October 2015, Moon Express announced a launch contract with Rocket Lab USA for 3 launches to the Moon beginning in 2017. In 2016, Moon Express announced an agreement with the U.S. Air Force to utilize Cape Canaveral Launch Complexes 17 and 18 for the development of its spacecraft.
The Moon Express founders, Dr. Robert (Bob) Richards, Naveen Jain, and Dr. Barney Pell, believe in the long-term economic potential of the Moon to produce resources essential to humanity's future on Earth and in space.
For more information about Moon Express, visit: www.moonexpress.com
To reach the Moon with us: http://www.indeed.com/cmp/Moon-Express,-Inc.
Investor
Jan 2018
NAIAD is a drug discovery startup creating novel bioactive small molecules targeting G-protein coupled receptors (GPCRs).
NAIAD’s computational simulation and deep learning based platform leverages structural biological information to virtually screen billions of molecules against specific GPCRs, looking for the ones that present the desired biological profile.
The team of the company is composed of senior industry and academic researchers, biotech entrepreneurs and bioinformatics/chemoinformatics data scientists..
Our unique capabilities of protein motion sampling and ultra-high throughput virtual screening enable NAIAD to effectively search and screen a chemical space containing billions of molecules, hunting the ones with the highest potential of biological activity against the desired GPCRs, selecting the ones with the best pharmacodynamics and pharmacokinetics potential for further wet tests.
Experience · 6 entries
All (6)
Investments (4)
Founder (1)
2024
2020
2018
Investor
Aug 2018
Homework help, private lessons, and study guidance all in one place. Thousands of tutors ready to assist instantly, every day, all day, and in every subject!
Investor
Mar 2018
Moon Express, Inc. (MoonEx) is a privately funded commercial space company blazing a trail to the Moon to unlock its mysteries and resources with low cost robotic spacecraft products & services using exponential technologies. Driven by long-term goals of exploring and developing lunar resources for the benefit of humanity, the company has short-term business on-ramps of providing lunar transportation and services for government and commercial customers. NASA partnered with Moon Express in 2014 under its Lunar CATALYST program to help build the capability to return the United States to the surface of the Moon. In October 2015, Moon Express announced a launch contract with Rocket Lab USA for 3 launches to the Moon beginning in 2017. In 2016, Moon Express announced an agreement with the U.S. Air Force to utilize Cape Canaveral Launch Complexes 17 and 18 for the development of its spacecraft.
The Moon Express founders, Dr. Robert (Bob) Richards, Naveen Jain, and Dr. Barney Pell, believe in the long-term economic potential of the Moon to produce resources essential to humanity's future on Earth and in space.
For more information about Moon Express, visit: www.moonexpress.com
To reach the Moon with us: http://www.indeed.com/cmp/Moon-Express,-Inc.
Investor
Jan 2018
NAIAD is a drug discovery startup creating novel bioactive small molecules targeting G-protein coupled receptors (GPCRs).
NAIAD’s computational simulation and deep learning based platform leverages structural biological information to virtually screen billions of molecules against specific GPCRs, looking for the ones that present the desired biological profile.
The team of the company is composed of senior industry and academic researchers, biotech entrepreneurs and bioinformatics/chemoinformatics data scientists..
Our unique capabilities of protein motion sampling and ultra-high throughput virtual screening enable NAIAD to effectively search and screen a chemical space containing billions of molecules, hunting the ones with the highest potential of biological activity against the desired GPCRs, selecting the ones with the best pharmacodynamics and pharmacokinetics potential for further wet tests.
Show all 6 entries ↓
Investment activity
2018–2024 · 4 investments
Recent (last 2 years)Earlier
